Fortrea
Daniela Gussetti is an experienced Clinical Research Associate II currently working at Fortrea since July 2023. Prior to this role, Daniela served as a CRA & Start Up Regulatory Specialist at Evidenze Health S.r.l. from April 2022 to July 2023, overseeing on-site monitoring of various clinical projects. Daniela's extensive background includes a role as Clinical Study Coordinator at the National Cancer Institute - Centro di Riferimento Oncologico di Aviano from October 2012 to April 2022, managing activities for a wide range of oncological studies. Earlier experience includes working as a Pharmaceutical Representative at UCB Pharma and conducting experimental thesis work at GlaxoSmithKline. Educational qualifications include a Second Level Professional Master’s Degree in Preclinical and Clinical Research from Università degli Studi di Parma, among other certifications and degrees in clinical research and pharmaceutical chemistry.
This person is not in any teams
This person is not in any offices
Fortrea
13 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.